Asitri Dashboard
Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 461
Selected: 0
NCT ID | Title | ||
---|---|---|---|
NCT03372720 | Fractional CO2 Laser Therapy in Minimizing Genitourinary Syndrome of Menopause in Gynecological Cancer Survivors | ||
NCT04427566 | Low Dose Whole Lung Radiation Therapy for Patients With COVID-19 and Respiratory Compromise | ||
NCT05102773 | The Effect of the Microbiome on Immune Checkpoint Inhibitor Response in Melanoma Patients | ||
NCT02400060 | Telephone-Based Intervention in Increasing Adherence to Adjuvant Hormonal Therapy in Patients With Breast Cancer | ||
NCT02950220 | Pembrolizumab and Ibrutinib in Treating Patients With Relapsed or Refractory Non-Hodgkin Lymphoma | ||
NCT03333746 | Lenalidomide and Nivolumab in Treating Patients With Relapsed or Refractory Multiple Myeloma | ||
NCT00983944 | Rituximab and Combination Chemotherapy With or Without Bleomycin Sulfate in Treating Patients With Primary Mediastinal Large B-Cell Lymphoma | ||
NCT04906382 | Tislelizumab for the Treatment of Recurrent Mismatch Repair Deficient Endometrial Cancer | ||
NCT03364582 | Dietary Patterns, Metabolomics and Colorectal Cancer Risk | ||
NCT05141682 | Oral Azacitidine for the Treatment of Relapsed or Refractory T-cell Large Granular Lymphocytic Leukemia | ||
NCT00004173 | Oxaliplatin and Paclitaxel in Treating Patients With Metastatic or Unresectable Cancer | ||
NCT02831582 | Omega-3 Supplementation in Prevention of Aromatase Inhibitor-Induced Toxicity in Patients With Stage I-III Breast Cancer | ||
NCT01692340 | Novel 13C Carotenoids for Absorption and Metabolism Studies in Humans | ||
NCT03892044 | Duvelisib and Nivolumab in Treating Patients With Richter Syndrome or Transformed Follicular Lymphoma | ||
NCT01640340 | Ondansetron Versus Palonosetron Antiemetic Regimen Prior to Highly Emetogenic Chemotherapy(HEC) | ||
NCT03039140 | Cardiac Rehabilitation Program in Improving Cardiorespiratory Fitness in Stage 0-III Breast Cancer Survivors | ||
NCT06528769 | Study of All-Trans Retinoic Acid (ATRA) and Cemiplimab in Patients with Advanced Leiomyosarcoma | ||
NCT05243069 | Head and Neck Cancer Patient Symptom and Oncologic Outcomes | ||
NCT04312789 | Avatrombopag for the Treatment of Thrombocytopenia After Donor Hematopoietic Stem Cell Transplant | ||
NCT01740648 | Trametinib, Fluorouracil, and Radiation Therapy Before Surgery in Treating Patients With Stage II-III Rectal Cancer | ||
NCT06026657 | Gemcitabine and Ex Vivo Expanded Allogenic Universal Donor, TGFβi Natural Killer (NK) Cells with or Without Naxitamab (Danyelza) for the Treatment of Patients with Metastatic, GD2 Expressing, HER2 Negative Breast Cancer | ||
NCT06582030 | Stop Addiction Stigma | ||
NCT02090530 | Precision Cancer Medicine for Advanced Cancer Through High-throughput Sequencing | ||
NCT00201825 | A Phase II Study of Capecitabine and Docetaxel in Previously Untreated Advanced Non-Small Cell Lung Cancer Patients | ||
NCT06500065 | 68Ga-DOTATATE PET/CT for the Diagnosis of Soft Tissue Sarcomas | ||
NCT04395274 | Young Adult EC Use and Respiratory Outcomes | ||
NCT02944565 | Daratumumab in Treating Patients With Multiple Myeloma | ||
NCT00201773 | Exemestane With Celecoxib as Neoadjuvant Treatment in Postmenopausal Women With Stage II, III, and IV Breast Cancer | ||
NCT00276120 | Identification of Novel Genetic Factors That Contribute to Risk for Breast Cancer | ||
NCT06038526 | Evaluation of Canakinumab in High-Risk Former-Smokers | ||
NCT00230126 | OSI-774 in African American Patients With Advanced and Previously Treated Non-Small Cell Lung Cancer | ||
NCT03568526 | Sensorimotor Rehabilitation Program in Improving Quality of Life in Patients With Early Stage Breast Cancer | ||
NCT05417165 | Anti-pneumococcal Vaccine Strategy in Patients with Chronic Lymphocytic Leukemia | ||
NCT02760030 | Endocrine Therapy Fulvestrant & Palbociclib or Aromatase Inhibitor Therapy in Treating Older Patients With Hormone Responsive Breast Cancer That Cannot Be Removed by Surgery | ||
NCT04602026 | The RIOT Trial: Re-Defining Frailty and Improving Outcomes With Prehabilitation for Pancreatic, Liver, or Gastric Cancer | ||
NCT00143065 | Fludarabine, Rituximab, and Alemtuzumab for B-Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma | ||
NCT03102866 | Aerobic and Strength Training Exercise in Improving Fitness and Arm Health During and After Radiation Therapy in Patients With Stage II-III Breast Cancer | ||
NCT04452526 | I Vaccinate: Testing Multi-Level Interventions to Improve HPV Vaccination | ||
NCT02507765 | Stereotactic Body Radiation Therapy and Transarterial Chemoembolization in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery | ||
NCT00601926 | Bevacizumab in Treating Patients With Unresectable or Metastatic Kidney Cancer | ||
NCT05379166 | Venetoclax and Azacitidine for Treatment of Therapy Related or Secondary Myelodysplastic Syndrome | ||
NCT01987726 | Comprehensive Gene Sequencing in Guiding Treatment Recommendations Patients With Metastatic or Recurrent Solid Tumors | ||
NCT05349227 | Comprehensive Outcomes for After Cancer Health | ||
NCT03824327 | Papaverine and Stereotactic Body Radiotherapy (SBRT) for Non Small Cell Lung Cancer (NSCLC) or Lung Metastases | ||
NCT03139227 | Apigenin in Increasing Health Benefits in High Risk Breast Clinic Patients | ||
NCT01465776 | Freeze-Dried Black Raspberries in Treating Patients With Oral Squamous Cell Cancer Undergoing Surgery | ||
NCT01559194 | Low Fat Versus Protein Sparing Diet for Weight Loss & Impact on Biomarkers Associated With Breast Cancer Risk | ||
NCT05236894 | Appeal of Nicotine Pouches Versus Cigarettes in the Ohio Appalachia Population | ||
NCT06031194 | Pharmacogenomics Effects on High-Dose Methotrexate Clearance in Patients With Diffuse Large B-Cell Lymphoma | ||
NCT01462773 | Study of Patients With Stage IV Malignant Melanoma Using PS-341 (Bortezomib, Velcade) and Interferon-alpha-2b in Malignant Melanoma |